03Apr 2023
Synthetic biology, genetic circuits and machine learning: a new age of cancer therapy

Synthetic biology, genetic circuits and machine learning: a new age of cancer therapy

Recent studies have shown how the combination of artificial intelligence and synthetic biology has enabled the development of engineered T cells for cancer immunotherapy. These studies have explored non-naturally occurring combinations of immune receptors and zinc fingers and how they can be arranged and controlled to improve the anti-tumor phenotype of T cells. The results of these studies demonstrate the potential for gene circuits of the future to respond to multiple environmental cues, including target cell antigen expression, tumor microenvironment composition, and small molecule drugs.

  • #oncology

Like

Save

Share